Kite Pharma's Mezzanine Round

Kite Pharma raised a round of funding on April 28, 2014.

Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of cancer immunotherapy products, with a primary focus on eACT designed to restore the immune system's ability to r…

Articles about Kite Pharma's Mezzanine Round: